The diagnosis and treatment of pacemaker-associated infection

Background Approximately 105 000 cardiac electronic devices are newly implanted in Germany each year. Germany has the highest implantation rate with respect to population of any European country. Infections in cardiac implants are serious complications, with an associated in-hospital mortality of 5–15%. It is thus very important to optimize the diagnostic and therapeutic strategies by which such infections can be detected early and treated effectively.